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Abstract
The body surfaces of humans and other animals are colonized at birth by microorganisms. The 
majority of microbial residents on the human body exist within gastrointestinal (GI) tract 
communities, where they contribute to many aspects of host biology and pathobiology. Recent 
technological advances have expanded our ability to perceive the membership and physiologic 
traits of microbial communities along the GI tract. To translate this information into a mechanistic 
and practical understanding of host-microbe and microbe-microbe relationships, it is necessary to 
recast our conceptualization of the GI tract and its resident microbial communities in ecological 
terms. This review depicts GI microbial ecology in the context of 2 fundamental ecological 
concepts: (1) the patterns of biodiversity within the GI tract and (2) the scales of time, space, and 
environment within which we perceive those patterns. We show how this conceptual framework 
can be used to integrate our existing knowledge and identify important open questions in GI 
microbial ecology.
Animals have evolved on a planet predominated by microorganisms. To facilitate survival in 
this microbial world, animals have developed mechanisms for supporting vast communities 
of microorganisms (microbiota) on their body surfaces. The microbial cells residing on and 
within the adult human body are estimated to outnumber somatic and germ cells by an order 
of magnitude.1 Since the first documented observation of bacteria associated with the human 
body by Antonie van Leeuwenhoek in the late 1600s, human microbiota research has 
focused largely on microorganisms that could be cultured ex vivo.2 However, recent 
technological advances have helped reveal the deep biodiversity of the human microbiota 
and identified many functional contributions of the microbiota to our postnatal biology and 
pathobiology (reviewed by Bäckhed et al,3 Wostmann,4 Cheesman and Guillemin,5 and 
Kinross et al6). The collective genomes of our microbial residents (microbiome) encode 
physiologic capabilities that are absent from our own genomes. We can therefore consider 
each host and its associated microbiota as a “superorganism”—an emergent blend of host 
and microbial traits.7 The Human Microbiome Project and other interdisciplinary research 
initiatives are designed to characterize the composition and function of the human 
microbiome and to define the factors that pattern microbial life on the human body.8
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The gastrointestinal (GI) tract harbors the majority of the microbial cells that reside in the 
adult human body (10–100 trillion microbial cells) and therefore is an important setting to 
investigate the relationships between host and microbiota. The constituency of the human GI 
microbiota includes members of all 3 domains of life (Bacteria, Archaea, and Eukarya) as 
well as viruses. Although >70 candidate bacterial phyla have been discovered on our planet, 
only 10 bacterial phyla (deep bacterial lineages, also known as divisions) have been 
observed in the human intestine (Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, 
Fusobacteria, Verrucomicrobia, Cyanobacteria, TM7, Spirochaetes, and VadinBE97) and 
only 8 bacterial phyla have been observed in the stomach (Proteobacteria, Firmicutes, 
Bacteroidetes, Actinobacteria, Fusobacteria, TM7, Deferribacteres, and Deinococcus-
Thermus).3,9–13 Within these few deep bacterial lineages there exists an abundance of 
diversity at shallower phylogenetic resolution; there are estimated to be >15,000 species-
level bacterial phylotypes associated with the human GI tract.10 The human GI tract also 
contains abundant and diverse viral and phage communities that can serve as predators of 
microbial cells and as reservoirs of genetic material that can expand microbial diversity.14–16 
In contrast, the archaeal population in the human GI tract is dominated by a single species, 
Methanobrevibacter smithii, which contributes important metabolic activities to the 
intestinal ecosystem.11,17–19 There is also a low level of eukaryotic diversity in the GI tract, 
and the roles of these organisms within the larger microbial community remain to be 
defined.20,21
To understand the form and function of the GI microbiota, it is helpful to view this complex 
microbial community through the lens of ecology. Historically, ecological inquiry has 
focused on analysis of macroscopic organisms, yet there is considerable interest in applying 
relevant ecological concepts to the microbial world. An important challenge for future 
research is to determine whether ecological principles discovered by study of macroscopic 
organisms can be directly applied to microbial communities.22–25 There are 2 general factors 
that limit our ability to apply an ecological perspective to the human GI microbiota. First, 
ecological theories and methods of investigation have not yet successfully permeated into 
the field of GI microbiota research. Second, data and associated insights into the human 
microbiota are limited. Ongoing research initiatives are expected to expand this knowledge 
base in the coming years, providing data that will be essential for testing and adapting 
ecological concepts in human GI environments.
An important feature of the GI microbiota that distinguishes it from non–host-associated 
microbial communities is its residence within a living multicellular host organism that is 
sensitive and responsive to its microbial residents. The responses of a host to its microbial 
inhabitants can alter the selective pressures within the GI environment that act upon 
microbial traits, which can in turn alter the microbial community. This reciprocal 
relationship between host and microbial community adds a rich layer of complexity to the 
analysis of GI microbial ecology and requires that host responses to microbes be 
incorporated into the study of GI ecology.
In this review, we frame the field of GI ecology in terms of 2 fundamental ecological 
concepts: pattern and scale.26 Pattern is defined as the variation of biodiversity within an 
ecosystem, whereas scale is defined as the spatial, temporal, and environmental dimensions 
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within which that variation is perceived. Pattern and scale are inextricably linked, because 
measurement of pattern occurs only within the context of a particular range of scales. A 
comprehensive understanding of the GI ecosystem will require us to appreciate patterns and 
their underlying causes along the continuum of scales.27 This review describes the different 
kinds of patterns that can be perceived within the GI ecosystem and then discusses the range 
of scales along which researchers can perceive those patterns. We then highlight how 
concepts of pattern and scale are being combined in the study of biogeography within the GI 
tract.
Defining Patterns in GI Microbial Ecology
Variation within an ecosystem such as the GI tract results in different kinds of patterns. 
These include patterns in the membership, function, and localization of the GI microbial 
community, as well as patterns of microbe-microbe and host-microbe relationships. 
Detection and description of patterns in the GI ecosystem are important prerequisites for 
understanding how patterns are established, how they change in response to different factors, 
and the consequences of pattern on microbial and host biology. In the following text we 
review the different types of patterns that have been described in the GI ecosystem.
Patterns in Microbial Community Membership
Variation in the membership of microbial lineages within a community is the most common 
pattern used to describe and compare microbial communities. Traditional methods for 
analyzing microbial community membership relied largely on cultivation of 
microorganisms. The principal limitation of cultivation-based approaches is that 
approximately 80% of all microbial members of the GI microbiota currently cannot be 
cultivated outside the GI tract.11 However, advances in microbial culture methods are 
increasing the fraction of the community that can be cultivated,28 and novel high-throughput 
culture-based phenotyping methods can help rapidly identify microbial community members 
with specific functional traits.29 Although culture-based methods remain indispensable for 
isolating individual microorganisms for physiologic and molecular analyses, rapid advances 
in DNA sequence-based methods have dramatically expanded our ability to survey 
biodiversity in a microbial community. Gene sequences derived from small subunit 
ribosomal RNA (SSU rRNA; 16S rRNA in Bacteria and Archaea, and 18S rRNA in 
Eukarya) have been used extensively for phylogenetic analysis.30 SSU rRNA genes are 
encoded in the genomes of all cellular organisms and are highly conserved but contain 
regions of sequence variability sufficient to distinguish between specific microbial groups. 
SSU rRNA sequences can be clustered based on selected levels of sequence identity into 
operational taxonomy units to provide an operational measure of microbial phylogeny and 
diversity without culture bias.31 An important consideration in any taxonomic analysis is the 
definition of a species, because such criteria often serve as the basis for sorting organisms 
into genetic lineages. There is surprisingly little consensus regarding the definition of 
prokaryotic species, and current methods have not kept pace with the discovery rate of new 
prokaryotic diversity.32 DNA-DNA hybridization methods and multilocus sequence analysis 
are often used for defining species in culturable isolates; however, the relative ease and 
culture independence of SSU rRNA sequence analysis has caused this method to emerge as 
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the predominant taxonomic metric. Species-level phylotypes are defined as operational 
taxonomy units sharing ≥97% or ≥99% identity, depending on the study. Although broadly 
utilized, this definition is debated due to genomic variation between members of a species-
level phylotype. Comparison of 32 Escherichia coli and Shigella strain genomes33 and 6 
Streptococcus agalactiae strain genomes34 revealed that many genes are found in only a 
subset of strains (the “dispensable genome”) while other genes are found in all tested strains 
(the “core genome”).35 One potential cause of this genetic variation is the high rate of lateral 
gene transfer observed in genomic analysis of enteric prokaryotes.36,37 This genetic 
exchange between community members serves as a potential source of genetic diversity and 
is believed to be a result of phage, mobile elements, and conjugal transfer.15,36,37 Despite 
these caveats, analysis of SSU rRNA sequences can provide important insights into the 
structure of a microbial community beyond the classification of observed phylotypes. 
Because most SSU rRNA sequence-based analyses of microbial communities do not reach 
saturation (ie, relatively rare community members are not detected), observed SSU rRNA 
sequences can be binned into operational taxonomy units to permit estimation of “true” 
biodiversity within that community using statistics such as richness (the number of 
phylotypes in an area), diversity (the number of phylotypes in an area weighted for relative 
abundance), and evenness (the relative abundance with which species are observed in an 
area).38,39 DNA sequences derived from SSU rRNA genes (or other genes) in different 
microbial communities can also be used to directly compare the phylogenetic structures of 
those microbial communities (reviewed by Lozupone and Knight39).
Genomic DNA extracted from a microbial community can be used for a spectrum of SSU 
rRNA sequence-based phylogenetic approaches to define microbial community composition 
(reviewed by Dethlefsen et al40 and Zoetendal et al41). These include rapid and cost-
effective methods that provide a “fingerprint” of the microbial diversity within a community 
(eg, T-RFLP,42 ARISA,43 and DGGE/TGGE44), sensitive methods for detecting specific 
community members (eg, quantitative polymerase chain reaction45,46 and high-density SSU 
rRNA microarrays47–49), and SSU rRNA sequencing methods that provide maximum 
phylogenetic information (eg, Sanger sequencing of SSU rRNA clone libraries and 
pyrosequencing of amplified pools of SSU rRNA genes50,51). While culture-independent 
sequence-based methods for defining community composition have revolutionized our 
understanding of microbial diversity in the GI tract, there are caveats to these methods. 
Different microbial species can display distinct susceptibilities to specific cell lysis and 
DNA extraction methods,52 and the selection of polymerase chain reaction primers to 
amplify SSU rRNA genes can also impact on the observed diversity within a sample.53 
Furthermore, it is important to recognize that different microbial genomes encode variable 
numbers of SSU rRNA genes, potentially leading to apparent phylotype abundances that do 
not accurately represent cellular abundance.54
Sequence-based phylogenetic surveys have revealed major patterns in the membership of the 
GI microbiota. The human intestinal microbiota at homeostasis is numerically dominated by 
members of just 2 bacterial phyla: Firmicutes and Bacteroidetes.9–11,51 The prevalence of 
Firmicutes and Bacteroidetes is not absolute along the length of the GI tract, because the 
stomach is instead predominated by members of the Proteobacteria phylum.12 Moreover, 
distinct alterations in the membership of the intestinal microbiota have been associated with 
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a growing spectrum of human diseases (reviewed by Kinross et al6), including inflammatory 
bowel disease (reviewed by Sartor55 and Sokol et al56) and obesity (reviewed in the 
following text and by DiBaise et al57).
Patterns in Microbial Community Function
Microbial community membership continues to serve as the predominant basis for analyzing 
and comparing microbial communities; however, several new complementary approaches 
are extending our ability to perceive patterns of microbial community function in the GI 
tract. Whereas phylogenetic methods utilize microbial lineages as a measure of community 
membership, metagenomic methodologies utilize the microbiome and its encoded products 
as a culture-independent measure of the potential activities of a microbial community 
(reviewed by Zoetendal et al,41 Medini et al,58 and Turnbaugh and Gordon59). Most 
metagenomic analyses of the GI microbiota to date have focused on shotgun sequencing of 
genomic DNA isolated directly from the intestinal microbial community in humans and 
mice.51,60–62 These data are providing early insights into the gene content and physiologic 
potential of the intestinal microbiome, including enrichment of genes involved in 
metabolism of carbohydrates, amino acids, and xenobiotics, synthesis of vitamins, and 
methanogenesis.51,60 Patterns of in vivo microbial transcription and translation can also be 
analyzed by isolating and quantifying RNAs (metatranscriptomics63–67) and proteins 
(metaproteomics68). These methods provide important complementary perspectives to 
genomic DNA sequence analysis, because the patterns of bacterial gene expression can be 
strongly influenced by multiple factors in vivo, including host developmental stage,67 
nutrient availability,63,66,67 and the presence of other microbial species.17,64
The in vivo biological activity of the human microbiota can also be monitored by isolating 
metabolites from specific anatomic compartments within the host and analyzing them using 
mass spectrometry and nuclear magnetic resonance methodologies.69 This strategy is based 
on the observation that the GI microbiome encodes enzymatic capabilities that are not 
encoded in our own genome51,60 and that identifiable microbial metabolites and 
cometabolites (proxies for microbial enzymatic activities) can be detected in multiple host 
compartments in correlation to the activities of the microbiome.70–72 For example, a genetic 
predisposition to impaired glucose homeostasis and nonalcoholic fatty liver disease in mice 
is associated with defects in choline metabolism, including low plasma phosphatidylcholine 
levels and microbiota-mediated urinary excretion of methylamines.70 The role of the 
microbiota on metabolite profiles in diverse host compartments was directly tested by 
comparing germ-free mice with those colonized with a normal microbiota. The microbiota 
was found to produce numerous metabolic changes in the intestine as well as extraintestinal 
compartments, including alterations in choline and bile acid metabolism.71 As our 
understanding of microbial metabolic diversity catches up with our new grasp of microbial 
phylogenetic and metagenomic diversity, the known microbial contribution to the host 
metabolome can be expected to expand.59
Patterns of Microbial Localization and Behavior
The spatial localization and dynamic behaviors of microorganisms in the GI tract can 
determine microbial community functions. In vitro studies have shown that spatial 
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organization of simple microbial communities can promote beneficial interspecies 
relationships and adaptive responses.73–75 It is likely that spatial organization serves a 
similar role in the complex microbial communities along the GI tract. Traditional approaches 
of light and electron microscopy allow estimation of spatial organization as well as 
microbial abundance; however, it can be difficult to distinguish between microbial species 
with similar physical properties using these methods. Fluorescence in situ hybridization 
using probes targeting SSU rRNA or other microbial genes has emerged as a common 
technique to provide highly quantitative information on the number and spatial localization 
of microbial lineages within the GI tract.76 Fluorescence in situ hybridization has also been 
coupled with stable isotope labeling and mass spectrometry to assay metabolic properties of 
individual microbial cells within a community.77
Many in vitro analyses have shown that microbial cells are capable of a diversity of 
behaviors, including different forms of motility, chemotaxis, adhesion, quorum sensing, and 
formation of spores and multicellular biofilms.78–80 These microbial behaviors are likely to 
have strong effects on microbial proliferation, dispersal, and persistence in the GI tract, as 
they do in other environments.81 Despite this acknowledged behavioral diversity in 
microorganisms, our understanding of how microbial behavior impacts GI microbial ecology 
and host biology is remarkably limited. This can be largely attributed to the difficulties 
associated with in vivo monitoring of microbial localization and behavior in the GI tracts of 
humans and mammalian models. In vivo bioluminescence assays can reveal localization of 
specific microbial lineages within mammalian hosts, but their spatial resolution is not 
sufficient to view individual cells.82 The optical transparency of the zebrafish model system 
presents new opportunities to view microbial behavior in a living vertebrate intestine. This 
model was recently used to reveal that individual microbial cells within the intestine can 
display a diversity of behaviors in vivo, ranging from rapid motility to formation of biofilms 
to physical interaction with the intestinal mucosa.83 A comprehensive understanding of the 
GI ecosystem must incorporate the contribution of distinct microbial behaviors to 
community membership and function.
Patterns of Microbe-Microbe and Host-Microbe Relationship
Understanding relationships between individual microbial cells, between groups of 
microbes, and between microbes and their host is fundamental to our understanding of the 
GI ecosystem. These relationships can be considered as emergent patterns generated by the 
membership, activity, and localization of the microbial community. Host-microbe and 
microbe-microbe relationships have traditionally been defined along a continuum ranging 
from pathogenic to commensal to mutualistic (see definitions in Table 1).23,25 The intricate 
relationship between a host and its GI microbiota is generally considered to be mutualistic 
because the microbiota gains a relatively stable nutrient-rich environment while the host 
gains extended digestive capabilities and exclusion of potential pathogens. This 2-
dimensional concept of a pathogen-mutualist range can be operationally useful; however, the 
potential complexity of relationships and the physiologic/genomic flexibility of individual 
species demand a more sophisticated perspective. Any 2 organisms within an ecosystem are 
likely to interact in multiple ways via their spatial relationship within a habitat and also via 
their metabolic relationships within a niche. A relationship between 2 organisms (or groups 
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of organisms) that is defined as pathogenic by one set of criteria might be defined as 
mutualistic by another. For example, the parasitic protozoan Toxoplasma gondii and the 
bacterium Helicobacter pylori can be classified as human pathogens using a specific set of 
criteria. However, recent evidence suggests that each of these organisms may have evolved 
as mutualists by providing protection from other pathogens and gastroesophageal reflux 
disease, respectively (personal communication, Laura Knoll, December 2008).12 How we 
define a relationship therefore depends on how we measure benefit and detriment as well as 
the breadth and accuracy of our perceptual abilities.
An important step toward elucidating relationships between organisms is to understand the 
different strategies used in those relationships. Ecological theory and in vitro models have 
been developed to describe social strategies used by microbes in competition, cooperation, 
cheating, and food web interactions,25,75,81,84 but these theories remain largely untested in 
the context of the GI tract. Analysis of gnotobiotic animal hosts colonized with simple 
microbial communities is providing early insights into the utilization of these social 
strategies by enteric microbes. Colonization of germ-free mice with a simple microbial 
community consisting of the bacterium Bacteroides thetaiotaomicron and the archaeon 
Methanobrevibacter smithii resulted in elevated colonization density and production of 
short-chain fatty acids compared with animals colonized with either microbial species 
alone.17 This cooperative microbe-microbe interaction also conferred an apparent benefit to 
the host by enhancing energy storage. Relationships between microbial species will be 
influenced by the degree of modularity and functional redundancy within the ecosystem. A 
recent analysis of glycoside hydrolases and glycosyltransferases in the genomes of gut-
derived microbial species and non-gut microbes revealed a significant convergence of these 
genes in gut-derived species, indicating a high degree of functional redundancy among gut 
microbes for those enzymatic activities.36
As described previously, patterns of biodiversity in the GI tract can be perceived in multiple 
ways, and these patterns need to be integrated to fully understand the structure and function 
of the GI microbiota. For example, measurements of community membership combined 
with metagenomic analysis of the same community can build associations between dominant 
community members and specific gene content.51,61,62 Paired assessment of GI microbiota 
membership and host metabolomic profiles can also reveal novel associations between 
specific community members and specific metabolic activities.72 These integrated patterns 
of biodiversity in the GI tract will become increasingly important as we attempt to gain a 
mechanistic understanding of how patterns change between diverse host environments, 
between different spatial locations within a host, and over time.
Defining Scales in GI Microbial Ecology
Any ecosystem, including the GI tract, exists along temporal, spatial, and environmental 
scales; these scales define 3 conceptual dimensions within which the GI ecosystem exists 
(Figure). However, any single analysis of an ecosystem is performed using a limited range of 
scales: “a low-dimensional slice through a high-dimensional cake.”26 This restricted range 
of scale is imposed by our experimental design as well as limitations in our perceptual 
capabilities. This is important because different scales might be subject to different selective 
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processes. Fine temporal and spatial scales can generally provide greater detail yet be more 
susceptible to stochastic events, whereas coarser scales can be more regular and predictable. 
We must therefore recognize the biases associated with each scale and develop an 
understanding of the interaction among phenomena on different scales. It is helpful to first 
consider how temporal, spatial, and environmental scales apply to the GI ecosystem.
Temporal Scales
Patterns within the GI ecosystem and their underlying selective forces can change over the 
course of seconds, minutes, hours, days, and years (Figure 1). Moreover, different 
communities may display varied levels of stability and resilience. The temporal distance 
between sampling time points in an experiment can therefore impact the resulting 
observations and interpretations. Many of the recent analyses of the GI microbiota have 
focused on either a single time point in individual hosts10,11,60,71,72,85 or multiple time 
points taken from the same individual host over the course of days or weeks.9,50,51 Some of 
these recent studies have provided insights into the temporal scales over which the GI 
microbiota changes in response to different types of perturbation. When obese people were 
switched to a low-calorie diet, their fecal microbiotas displayed a gradual phylum-wide 
decrease in the ratio of Firmicutes to Bacteroidetes over the course of 1 year.9 In contrast, 
treatment of healthy people with ciprofloxacin for only 3–5 days resulted in rapid and 
marked individualized reductions in diversity across all predominant bacterial phyla. 
Remarkably, the pretreatment pattern of bacterial diversity was largely restored by 4 weeks 
after the end of ciprofloxacin treatment, indicating that the GI microbiota is highly 
resilient.50 These results show the wide range of temporal scales over which patterns of 
community membership can change and highlight the need to extend analysis of the GI 
ecosystem to finer temporal scales (ie, hours, minutes, and seconds). It will be instructive to 
correlate patterns of microbial community membership with patterns of microbial activity 
and localization at these finer temporal scales.
Spatial Scales
Beginning at the “top” of the spatial scale, we can perceive patterns of variation between 
individual hosts (Figure 1). Recent analysis of the GI ecosystem has been biased toward this 
spatial scale, in which individual hosts are compared using samples obtained from a 
common anatomic site such as biopsy of the intestinal mucosa,10,11 feces,9,11,50,51,60 
intestinal contents,61,62,85–87 or whole intestinal segments.71,87 The selection of analytic 
method can have a profound impact on our ability to perceive patterns in GI microbial 
ecology at the scale of individual hosts. 16S rRNA sequence-based comparisons of human 
fecal microbiota have revealed high levels of interindividual variation9,11,50,88 and have 
indicated that the number of species-level phylotypes shared across individuals is 
exceedingly rare or nonexistent.51 In contrast, metagenomic analyses of gene content in the 
fecal microbiome of different human hosts revealed a wide array of microbial gene families 
that are shared between individuals. These data indicate that a “core microbiome” shared 
between human hosts exists at the level of gene content but not at the level of microbial 
lineages. This implies the existence of significant functional redundancy between dominant 
members of the GI microbiota and suggests that each host environment exerts selective 
pressures on microbial traits rather than on microbial taxonomy.51
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The proximal-distal axis of the alimentary tract provides microbes with a range of physical 
habitats and metabolic niches determined by salient differences in anatomy, physiology, and 
nutrient availability. Selective pressures that act on the microorganisms at different 
proximal-distal locations along the alimentary tract can result in compositionally distinct 
microbial communities. This is evident in the increasing density of microbial cells 
proceeding from the proximal small intestine (103 cells/g contents) to the colon (1011 cells/g 
contents),1 the significant compositional differences between the bacterial communities in 
the stomach (usually predominated by Proteobacteria12) and intestine (usually predominated 
by Firmicutes10), as well as relatively minor differences in microbial community 
composition between different regions of the large intestine.11 To understand the 
mechanisms that underlie community structure and function at any point along the proximal-
distal axis of the GI tract, we must also consider the radial axis that spans the lumen, mucus 
layer, and epithelium of the GI tract. A prominent feature of the radial axis is the mucus 
layer covering the epithelium. The mucus layer provides a dynamic physical barrier that 
separates enteric microbes from the host epithelium76,89 while simultaneously serving as a 
diffusion barrier for antimicrobial peptides and other factors released by host cells.90 O- and 
N-linked glycans associated with mucins also provide a nutrient source for enteric 
microbes,67 which can serve as an important determinant of persistence within the GI tract 
habitat.66 Selective pressures that act at distinct locations along the radial axis are therefore 
likely to influence the organization, composition, and activity of the local microbial 
community. For example, the fecal microbiota and colonic mucosal-adherent microbiota 
from the same individual contain distinct microbial lineages.11 Moreover, liquid and 
particulate fractions of human feces contain distinct patterns of microbial diversity.91 Further 
culture-independent analysis is required to describe the distribution of microbial lineages 
along the proximal-distal and radial axes of the GI tract and the consequences of these 
microbial localization patterns to GI ecology.
The emergent properties of the microbiota and its contribution to host biology are a result of 
the interactions between microbial cells and host cells. By perceiving the GI ecosystem on 
the spatial scale of cellular interactions, we can begin to discern the mechanisms that 
underlie the functional relationships between different microbial and host cells. Microbe-
microbe interactions can be perceived at several levels, including interactions between 
operational groups of microbes, between different microbial species, and between members 
of the same microbial species. As described previously, microbial cells can utilize a variety 
of behaviors and communication mechanisms to establish relationships with other microbes 
in their habitat.79–81 Elucidating relationships between microbial cells in the context of the 
complex normal GI microbiota poses daunting challenges. It can therefore be useful to 
experimentally reduce the complexity of the microbial community. Gnotobiotic animal 
models, in which all microbial life can be defined or excluded, provide opportunities to 
control the complexity of the GI microbial community and thereby study specific 
relationships between microbial cells. Analysis of simple communities consisting of only a 
few defined microbial lineages in gnotobiotic hosts is beginning to reveal the nature of 
microbial relationships in heterogeneous ecosystems.17,64,66 In vitro culture systems that 
mimic conditions within the GI tract can also be used to study interactions between normal 
members of the GI microbiota,92 although microbes can display important phenotypic 
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differences between in vitro and in vivo environments.63,66 An often-overlooked factor in 
microbial relationships is the issue of phenotypic heterogeneity. Even within a community 
consisting of only a single bacterial species, there is marked phenotypic heterogeneity 
because of stochastic changes in transcription and translation in individual microbial cells.93 
The contribution of this phenotypic heterogeneity to the form and function of complex 
microbial communities like the GI microbiota remains unclear.
At the “bottom” of the spatial scale, we can analyze the molecules that comprise the 
microbial cells, host cells, and interstitial spaces within the GI ecosystem. Microbial genome 
sequencing projects have revealed patterns of genome organization and the evolutionary 
history of microbes adapted to the GI tract18,37,62,94 while providing valuable references for 
interpreting metagenomic data sets.8,51 Metagenomic and metabolomic approaches 
described previously are providing unprecedented insights into the gene content and 
physiologic capabilities of GI microbiomes.59 A long-term goal for microbiome research is 
to empirically define the functions of identified microbial genes as well as the processes and 
metabolic networks in which they participate. It will be equally important to understand how 
the molecular biology of different host cell types is altered as a function of microbial 
community composition and activity. Tools and concepts cultivated in the field of systems 
biology will be especially useful for modeling and analyzing genetic and metabolic 
networks in the GI ecosystem.27 Successful implementation of these systems biological 
approaches will require an understanding of the activity of genes and gene products encoded 
in the microbiome and the host genome as well as the transcriptional and translational 
mechanisms that regulate their expression. Genetic and molecular analysis in representative 
cultivatable members of the GI microbial community are beginning to reveal the function of 
specific gene products,66,95–97 but many additional microbial genes remain to be 
functionally characterized in the context of the GI ecosystem.
Environmental Scales
To understand the principles that govern the ecosystem within the GI tract, it can be helpful 
to observe how the ecosystem changes as the host environment changes in different ways. 
Here we define “environment” from the perspective of the GI microbial community: all 
features of the habitat within the host as well as the features of the host's biosphere together 
comprise the environment in which the GI microbial community exists. This environment 
can be modified in different ways, including variation in the local biosphere in which hosts 
reside,85,87 host phylogeny,87,98 host genotype,99 host physiology (eg, age, metabolism, 
immunology, pathobiology),100 and host lifestyle (eg, diet, exposure to antibiotics and 
pathogens) (Figure 1).50,62,101,102 As described in the following text, variation along these 
environmental scales can alter the selective pressures within the GI ecosystem and can 
impact on microbe-microbe and host-microbe relationships.
Patterns Within Scales: Biogeography of the GI Ecosystem
The field of biogeography was founded more than 250 years ago by Carl Linnaeus and his 
colleagues, who studied the patterns of plant and animal biodiversity in diverse terrestrial 
environments. Recent advances in molecular phylogenetics, metagenomics, and 
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metabolomics have permitted the application of biogeography to the biodiversity of the 
microbial world.27,103 Because biodiversity can be defined by taxonomy as well as 
functional traits, the modern definition of biogeography could be broadened to the study of 
biological patterns within a range of scales. A comprehensive understanding of GI 
biogeography will therefore require knowledge of the many patterns within the GI 
ecosystem along the full range of spatial, temporal, and environmental scales. This 
integrated perspective must account not only for the microbiota and its component members, 
but also for the biology of the host and the reciprocal relationship between host and 
microbiota.
The biogeography of the GI tract is an important frontier of medical research because 
microbial dysbioses have been associated with a growing number of human diseases, 
including inflammatory bowel disease and obesity (reviewed by Kinross et al,6 Sartor,55 
Sokol et al,56 and DiBaise et al57). When a disease is associated with an alteration in GI 
microbiota composition or activity, a fundamental challenge is to determine whether the 
observed changes are causes and/or consequences of the respective disease. If microbial 
dysbiosis is found to be a consequence of host disease, it could be possible to develop new 
diagnostic and predictive tools for monitoring human health. If microbial dysbiosis is found 
to contribute to the etiology of disease, specific antibiotic/prebiotic/probiotic/postbiotic 
approaches could be used to control abundance or activity of the implicated community 
members.104,105
Host Habitat Effects on the Microbial Community
A fundamental goal in biogeography research is to understand how the local environment 
influences biodiversity. The Baas-Becking hypothesis proposes that all microbial life is 
distributed worldwide but that the local environment selects upon, and is therefore in part 
responsible for, the variation in microbial biodiversity between different 
environments.106,107 Initial tests of the Baas-Becking hypothesis within the context of the GI 
tract have focused on the relative contribution of the local biosphere (eg, differences in the 
local microbial community available to colonize the host or the composition of the 
parentally transmitted microbial community) to GI microbiota composition. The 
composition of the fecal microbiota in babies delivered by cesarean section is often 
compositionally distinct from babies delivered vaginally,108–110 although the infant fecal 
community is also susceptible to significant stochastic effects.88 Phylogenetic comparisons 
of the cecal microbiota from mouse pups and their mothers revealed that the pups' microbial 
community resembled that of their mother.85 These results show that the microbial 
community within the local biosphere can influence the composition of the GI microbiota. 
However, specific selective pressures might act within the habitat of the host GI tract (host 
habitat effects; eg, host immunity, physiology, and diet) to further shape the diversity of the 
GI microbiota. A role for host habitat effects in GI microbial diversity was tested by 
colonizing germ-free mice and zebrafish recipients with intestinal microbiotas obtained from 
conventionally raised zebrafish and mouse donors, respectively. Phylogenetic analysis 
revealed that when a microbial community is transferred to a new host, the relative 
abundance of the bacterial lineages in the transplanted microbial community change to 
resemble the normal intestinal microbial community composition of the recipient host.87 For 
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example, colonization of germ-free mice with a zebrafish intestinal microbiota predominated 
by Proteobacteria resulted in an output community with an amplification of the Firmicutes 
phylum that dominates the conventional mouse intestinal microbiota. The GI habitat within 
different hosts therefore helps shape microbial community composition in distinctive ways.
It is not clear which factors within a host habitat are responsible for selecting a specific 
microbial community; however, experiments in animal models are beginning to elucidate the 
contribution of host genotype and diet to GI microbial diversity. For example, mice with a 
homozygous knockout of Myd88, which encodes an adaptor protein for almost all Toll-like 
receptors (TLRs), consistently displayed reduced ratios of Firmicutes to Bacteroidetes and 
increased representation of specific families within these phyla (ie, Lactobacillaceae, 
Rikenellaceae, and Porphyromonadaceae) in their cecal microbiota compared with wild-type 
mice.111 It remains unknown how loss of Myd88 function causes this shift in community 
composition, but it is possible that selective pressures caused by Myd88-dependent 
production of antimicrobial proteins by Paneth cells help to shape microbial community 
structure.112 Phylogenetic analysis of the cecal microbiota in mice with a homozygous 
mutation in the gene encoding leptin receptor (ob/ob) and their wild-type siblings revealed 
that the obesity phenotype linked to the ob/ob genotype was associated with a phylum-wide 
increase in the ratio of Firmicutes to Bacteroidetes.85 Intriguingly, human obesity is also 
associated with a phylum-wide increase in the Firmicutes/Bacteroidetes ratio within the 
fecal microbiota, indicating that obesity might similarly alter selective pressures on GI 
ecology in both humans and mice.9 In contrast, a mouse model of diet-induced obesity 
showed an increased Firmicutes/Bacteroidetes ratio in the cecal microbiota that was caused 
by a marked amplification of the Mollicutes class within the Firmicutes phylum together 
with a phylum-wide suppression of Bacteroidetes.62 Metagenomic analysis of cecal 
microbiomes from these obese mouse models revealed that their increased Firmicutes/
Bacteroidetes ratios were associated with increased abundance of gene categories involved 
in metabolism of complex polysaccharides and other carbohydrates.61,62 The amplification 
of specific enteric bacterial taxa in the context of obesity could therefore be due to their 
enhanced capacity for nutrient harvest and/or their ability to thrive under other physiologic 
or immunologic conditions associated with the respective host obesity phenotype.
Taken together, these studies support the Baas-Becking hypothesis within the context of the 
GI environment and identify host genotype and diet as 2 important factors that govern the 
membership and physiologic potential of the GI microbial community. This notion is further 
supported by a recent comparison of fecal microbiotas from humans and 59 other 
mammalian species that identified diet and host phylogeny as key determinants of 
mammalian intestinal microbiota composition.98 The mechanistic bases for these distinct 
effects of host diet, genotype, and phylogeny on GI microbiota composition and activity 
have yet to be empirically determined. Importantly, previous studies have been focused on 
the spatial scale of individual hosts (Figure 1), and additional analysis will be required to 
measure these host habitat effects at finer spatial and temporal scales.
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Microbial Effects on the Host
In the analysis of GI biogeography, it is important to identify the mechanisms by which 
microbes communicate with their hosts and how host cells perceive and respond to these 
microbial cues. Alterations in the GI microbial community have been associated with a 
spectrum of disease states, although empirical effects of compositionally distinct microbial 
communities on host biology have only been defined in a few cases. The transcription factor 
T-bet is encoded by one of a group of genes implicated in the control of intestinal 
inflammation.55 Mice that lack functional T-bet are immunocompromised and display 
increased susceptibility to colitis. Interestingly, the colitis associated with T-bet deficiency 
was found to be communicable to T-bet-sufficient hosts, indicating that the absence of T-bet 
resulted in formation of a colitigenic microbial community.99 As described previously, an 
increased ratio of Firmicutes to Bacteroidetes is observed in mice that become obese due to 
deletion of the leptin receptor gene85 or consumption of a high-fat diet.62 Remarkably, 
introduction of intestinal microbial communities isolated from the obese mice into wild-type 
mice or mice fed a control diet, respectively, resulted in increased fat deposition.61,62 These 
studies illustrate the reciprocal relationship between microbiota and host: an alteration in the 
host habitat (ie, host genotype or diet) alters microbial community, which in turn alters host 
physiology. Although we have a working knowledge of the many host biological processes 
that are affected by enteric microbes (reviewed by Bäckhed et al,3 Wostmann,4 Cheesman 
and Guillemin,5 and Blaut and Clavel113), we understand relatively little about the microbial 
signals and host signal transduction mechanisms that mediate these effects. As summarized 
in the following text, significant advances have recently been made toward elucidating the 
host molecules and cells that facilitate microbial effects on host immunity and nutrient 
metabolism.
Members of the GI microbiota stimulate a program of homeostatic immune responses in 
intestinal epithelial cells as well as multiple populations of associated immune cells.105 
Microbes are detected by pattern recognition receptors that include the transmembrane TLR 
and the intracellular nucleotide-binding and oligomerization domain-like receptor families. 
TLRs and nucleotide-binding and oligomerization domain-like receptors recognize 
conserved microbe-associated molecular patterns produced by bacteria, parasites, fungi, and 
viruses.114,115 Microbe-associated molecular patterns such as lipopolysaccharide (a major 
component of the gram-negative bacterial outer membrane) and flagellin (the major 
structural subunit of the bacterial flagellar filament) are detected by specific members of the 
TLR family (TLR4 and TLR5, respectively).105,115 Upon binding to their respective 
microbe-associated molecular pattern, TLRs act together with the Myd88 adapter protein to 
induce intracellular signaling events that converge upon the nuclear factor κB (NF-κB) and 
mitogen-activated protein kinase pathways to regulate expression of genes involved in 
epithelial barrier fortification and inflammation.55,114,115 Hosts have evolved a range of 
mechanisms to mitigate their own innate immune responses to enteric microbes (reviewed 
by Neish105). For example, lipopolysaccharide produced by the microbiota stimulates 
production of intestinal alkaline phosphatase in the intestinal epithelium of both zebrafish 
and mice. Intestinal alkaline phosphatase acts at the brush border of intestinal epithelial cells 
to detoxify lipopolysaccharide and thereby reduce the proinflammatory potential of the 
microbiota.116,117
Camp et al. Page 13













The importance of the TLR and NF-κB pathways in host-microbe relationships has been 
determined in genetically engineered animal models. Analysis of Myd88-null mice, which 
have an increased susceptibility to colitis in the presence of the microbiota, indicates that 
microbial signals perceived by TLRs are required to prevent intestinal inflammation.118 
Mice that lack TLR5 develop spontaneous colitis, but this phenotype is rescued in animals 
that lack both TLR5 and TLR4.119 Therefore, different TLRs can have opposing roles in 
intestinal homeostasis despite having common downstream effector pathways such as NF-
κB. Experimental manipulation of the NF-κB pathway has revealed both anti-
inflammatory120 and proinflammatory121 roles for this transcriptional control pathway in the 
intestine, raising questions about the spatial and temporal patterns in which TLR and NF-κB 
pathways are activated in response to distinct microbial signals. Mice with intestinal 
epithelial-specific knockout of the genes encoding NF-κB essential modulator/Ikkγ122 or 
Ikkβ,123 which are 2 components of the IKK complex responsible for activation of NF-κB, 
were found to be susceptible to chemically induced colitis or develop spontaneous intestinal 
inflammation, respectively. Similarly, intestinal epithelial-specific deletion of RelA/p65, 
which encodes a primary subunit of the NF-κB transcription factor, caused elevated 
epithelial cell proliferation and apoptosis as well as increased susceptibility to colitis.124 
These results indicate that NF-κB activation in the intestinal epithelium promotes anti-
inflammatory responses to microbial signals. This anti-inflammatory role for NF-κB in the 
intestinal epithelium is consistent with in vivo analysis of NF-κB activation during intestinal 
inflammation. Induction of experimental colitis in mice that express the marker green 
fluorescent protein under control of NF-κB cis-elements revealed initial transient NF-κB 
activation in epithelial cells followed by induction of NF-κB in lamina propria cells.125 
Study of cell type–specific knockout animals is beginning to reveal the roles of TLR and 
NF-κB signaling pathways in specific cell types. For example, loss of Myd88 function 
specifically in dendritic cells established that TLR/Myd88-mediated MAMP recognition 
activates dendritic cells to produce proinflammatory cytokines and promote T-helper 
responses.126 Recent analysis of mice lacking Myd88 function specifically in Paneth cells 
revealed that intestinal bacteria are detected by Paneth cells through a cell-autonomous 
Myd88-dependent mechanism, resulting in production of antimicrobial proteins and 
fortification of the mucosal barrier.112 It will be important to continue to correlate specific 
TLR and NF-κB functions with the spatial and temporal patterns in which these pathways 
respond to microbial cues at intestinal and extraintestinal sites.
The GI microbiota is also an important regulator of dietary nutrient metabolism. The 
metabolic diversity encoded in the intestinal microbiome improves digestion efficiency of 
nutrients and permits the host to digest many nutrients that would be otherwise inaccessible. 
The encoded products of the human genome are insufficient for digestion of complex plant 
polysaccharides such as xylan-, pectin- and arabinose-containing carbohydrates. These 
complex polysaccharides enter the colon, where the microbiota produce various glycoside 
hydrolases, lyases, and esterases that aid the degradation of glycans into short-chain fatty 
acids and monosaccharides.60,61 Short-chain fatty acids are absorbed by the host, where they 
regulate colonocyte growth and differentiation,57 serve as an energy source for host tissues 
such as skeletal and heart muscles, and act as a substrate for lipogenesis in adipose tissue.127 
Monosaccharides liberated through microbial fermentation are also absorbed and transported 
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to the liver, where they induce de novo hepatic lipogenesis.86 The intestinal microbiota also 
contributes to host metabolism by deconjugating bile salts,71,128,129 salvaging urea, and 
synthesizing essential amino acids as well as K and B vitamins.127,130 These contributions 
of the microbiota to processing and uptake of dietary nutrients are accompanied by 
alterations in host energy balance. In contrast to the innate immune responses described 
previously, our understanding of the host pathways and processes that are impacted by these 
different products of microbial metabolism is much more limited. Colonization of germ-free 
mice with a normal microbiota results in increased serum glucose and insulin levels as well 
as suppression of intestinal epithelial expression of a peptide hormone called fasting-induced 
adipose factor (Fiaf/Angptl4).86 Fiaf synthesized in the intestinal mucosa is secreted into 
circulation, where it directly inhibits the activity of lipoprotein lipase to prevent fat 
deposition and also promotes fatty acid oxidation in muscle.86,131 Furthermore, germ-free 
mice homozygous for a Fiaf-null allele display higher lipoprotein lipase activities than their 
germ-free wild-type littermates and body fat content equivalent to wild-type conventionally 
raised littermates.86 These results support a model in which microbial activities regulate host 
energy balance by suppressing transcription of Fiaf in the intestinal epithelium, thereby 
promoting lipoprotein lipase activity and fat storage in peripheral tissues. The microbial 
factors and host signal transduction mechanisms that regulate intestinal expression of Fiaf 
are unknown but represent attractive targets for controlling host fat storage and energy 
balance.
Future Directions
The community of microorganisms that resides in the GI tract is a potent environmental 
factor contributing to human health and disease. The composition and activity of the GI 
microbiota could be used in diagnostic and prognostic measures of human health. 
Furthermore, reagents that target specific microbial lineages, gene products, and metabolic 
networks might be developed into new therapies to promote human health. Our ability to 
design accurate predictive measurements as well as safe and effective therapeutics will 
depend on our comprehension of patterns in GI ecology along spatial, temporal, and 
environmental scales. Each microorganism experiences the GI ecosystem on a unique range 
of scales, which together comprise the adaptive landscape in which it responds and evolves. 
There is no single correct scale in which to analyze GI microbial ecology. However, this 
does not mean that all scales are equally important and does not exclude the possibility that 
selective pressures acting on organisms change at different scales. Observations of 
variability and predictability in the GI ecosystem are interpretable only if we reference the 
range of scales that are relevant to the organisms or processes being examined.
The Human Microbiome Project and other research efforts are rapidly expanding our 
knowledge of microbial biodiversity on the landscape of the human body. However, recent 
molecular analyses of the GI ecosystem have generally focused on coarse temporal and 
spatial scales and have been largely limited to comparison between individuals. Analysis of 
GI ecology along finer spatial and temporal scales is therefore an important goal for future 
research. These efforts should be coupled with an increased appreciation for the reciprocal 
interactions between members of the microbial community and the host. Understanding the 
complexity of the GI ecosystem demands an integrated multidisciplinary approach that 
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combines the fields of gastroenterology, physiology, nutrition, immunology, microbiology, 
ecology, evolutionary biology, and systems biology. This approach will not only depend on 
development and implementation of molecular analytic methods, but also on in vitro culture 
systems that accurately mimic GI tract environments as well as experimentally tractable 
mammalian and non-mammalian animal model systems that permit reductionist analyses of 
the GI ecosystem. To navigate and integrate the diverse patterns emerging from this 
multidisciplinary field, we will need a clear vision of the different spatial, temporal, and 
environmental scales within which the GI ecosystem operates.
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Scales in GI microbial ecology. (A) The GI ecosystem can be conceptualized as a 3-
dimensional space defined by variation along environmental, spatial, and temporal scales. 
Environmental scales (y-axis) are defined by different types of variation affecting the GI 
environment, including variation in biosphere, host species, host genotype, host physiology, 
and host lifestyle. Spatial scales (x-axis) are defined by the spatial resolution at which the GI 
ecosystem is perceived. The upper macroscopic level consists of the individual host and 
progresses down through the levels of organ system, tissue, cell, and molecule. Note that the 
molecular spatial scale is illustrated here by molecules within a gram-negative bacterium, 
although this same scale can be applied to molecules of any host or microbial origin. 
Temporal scales (z-axis) are defined by the time over which variation in the GI ecosystem is 
perceived, beginning with the present and progressing into seconds, minutes, days, and 
years. B–D show how this conceptual frame of reference can be used to provide context for 
3 recent studies of the GI ecosystem. B depicts a phylogenetic comparison of the microbial 
community in the feces (spatial scale: organ) of different mammalian host species 
(environmental scale: host species) at a single time point (temporal scale: present).98 C 
depicts a phylogenetic comparison of the microbial community in the feces (spatial scale: 
organ) of individual healthy humans at multiday intervals (temporal scale: days) before and 
after treatment with the antibiotic ciprofloxacin (environmental scale: host lifestyle).50 D 
depicts a comparison of bacterial cell behavior (spatial scale: cells) in zebrafish intestines at 
different stages of development (environmental scale: host physiology) using real-time in 
vivo imaging (temporal scale: seconds).83
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Table 1
Glossary of Key Terms in GI Microbial Ecology
Term Definition
Biogeography The study of patterns of biodiversity along spatial, temporal, and environmental scales
Commensalism Relationship in which one partner benefits without detriment to the other
Conventionalized Animals derived germ-free and later colonized with a microbiota harvested from conventionally raised donors
Conventionally raised Animals raised under standard conditions in the presence of a normal microbiota
Germ-free Animals raised in the absence of all microorganisms; also called axenic
Gnotobiotic Animal or environment in which all microorganisms are excluded or known
Habitat Physical location or “address” occupied by an organism within an ecosystem
Metabolomics Identification and quantification of host and microbial metabolites in a particular host compartment
Metagenomics Culture-independent measure of the gene content and physiologic potential of a microbial community
Microbiome Collective genomes within a microbiota
Microbiota Collective community of microorganisms within a habitat
Mutualism Relationship in which both partners benefit; also called symbiosis
Niche Function or “profession” of an organism within an ecosystem
Pathogenesis Relationship in which one partner benefits to the detriment of the other; also called parasitism
Pattern The variation of biodiversity within an ecosystem
Phylotype Group of SSU rRNA gene sequences with ≥97%–99% sequence identity
Scale The spatial, temporal, or environmental ranges within which variation in an ecosystem is perceived
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